These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 21785119)

  • 21. Efficacy of inhaled ciprofloxacin agents for the treatment of bronchiectasis: a systematic review and meta-analysis of randomized controlled trials.
    Lim JU; Hong SW; Ko JH
    Ther Adv Respir Dis; 2019; 13():1753466619875930. PubMed ID: 31538535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of oral ciprofloxacin. An update based on clinical trial results.
    Schacht P; Arcieri G; Hullmann R
    Am J Med; 1989 Nov; 87(5A):98S-102S. PubMed ID: 2686432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa*.
    Drehobl M; Guerrero JL; Lacarte PR; Goldstein G; Mata FS; Luber S
    Curr Med Res Opin; 2008 Dec; 24(12):3531-42. PubMed ID: 19032135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ciprofloxacin pharmacokinetic profiles in paediatric sepsis: how much ciprofloxacin is enough?
    Lipman J; Gous AG; Mathivha LR; Tshukutsoane S; Scribante J; Hon H; Pinder M; Riera-Fanego JF; Verhoef L; Stass H
    Intensive Care Med; 2002 Apr; 28(4):493-500. PubMed ID: 11967606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of ciprofloxacin in paediatric patients--review.
    Kubin R
    Infection; 1993; 21(6):413-21. PubMed ID: 8132376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciprofloxacin (Otiprio) for tympanostomy tube insertion.
    Med Lett Drugs Ther; 2016 May; 58(1495):69-70. PubMed ID: 27192620
    [No Abstract]   [Full Text] [Related]  

  • 27. Arthropathy secondary to ciprofloxacin in an adult cystic fibrosis patient.
    Samuelson WM; Pleasants RA; Whitaker MS
    Ann Pharmacother; 1993 Mar; 27(3):302-3. PubMed ID: 8453165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The incidence of arthropathy adverse events in efalizumab-treated patients is low and similar to placebo and does not increase with long-term treatment: pooled analysis of data from Phase III clinical trials of efalizumab.
    Pincelli C; Henninger E; Casset-Semanaz F
    Arch Dermatol Res; 2006 Dec; 298(7):329-38. PubMed ID: 17021768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
    Johnston BC; Goldenberg JZ; Vandvik PO; Sun X; Guyatt GH
    Cochrane Database Syst Rev; 2011 Nov; (11):CD004827. PubMed ID: 22071814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and Efficacy of Intratympanic Ciprofloxacin Otic Suspension in Children With Middle Ear Effusion Undergoing Tympanostomy Tube Placement: Two Randomized Clinical Trials.
    Mair EA; Park AH; Don D; Koempel J; Bear M; LeBel C
    JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):444-51. PubMed ID: 26985629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paediatric formulations of artemisinin-based combination therapies for treating uncomplicated malaria in children.
    Bélard S; Ramharter M; Kurth F
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD009568. PubMed ID: 33289099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy.
    Laoprasopwattana K; Khwanna T; Suwankeeree P; Sujjanunt T; Tunyapanit W; Chelae S
    Pediatr Infect Dis J; 2013 Mar; 32(3):e94-8. PubMed ID: 23080291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a phase I, randomized, dose-escalation study.
    Stass H; Weimann B; Nagelschmitz J; Rolinck-Werninghaus C; Staab D
    Clin Ther; 2013 Oct; 35(10):1571-81. PubMed ID: 24054830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluoroquinolones in children with fever and neutropenia: a systematic review of prospective trials.
    Sung L; Manji A; Beyene J; Dupuis LL; Alexander S; Phillips R; Lehrnbecher T
    Pediatr Infect Dis J; 2012 May; 31(5):431-5. PubMed ID: 22189521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
    Miao XP; Li JS; Ouyang Q; Hu RW; Zhang Y; Li HY
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD007744. PubMed ID: 25340915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.
    Haworth CS; Bilton D; Chalmers JD; Davis AM; Froehlich J; Gonda I; Thompson B; Wanner A; O'Donnell AE
    Lancet Respir Med; 2019 Mar; 7(3):213-226. PubMed ID: 30658914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin.
    Schaad UB; Stoupis C; Wedgwood J; Tschaeppeler H; Vock P
    Pediatr Infect Dis J; 1991 Oct; 10(10):723-9. PubMed ID: 1945573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ciprofloxacin in critically ill children.
    Sideri G; Kafetzis DA; Vouloumanou EK; Papadatos JH; Papadimitriou M; Falagas ME
    Anaesth Intensive Care; 2011 Jul; 39(4):635-9. PubMed ID: 21823382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis.
    Aksamit T; Bandel TJ; Criollo M; De Soyza A; Elborn JS; Operschall E; Polverino E; Roth K; Winthrop KL; Wilson R
    Contemp Clin Trials; 2017 Jul; 58():78-85. PubMed ID: 28495619
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.